Explore more publications!

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

Press releases published on October 30, 2025

Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
GENFIT annonce son intention de procéder au retrait volontaire de la cotation de ses « American Depositary Shares » sur le Nasdaq Global Select Market
¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
‘Do I Qualify for Lung Cancer Screening?’: Understanding Your Path to Early Detection Could Save Your Life
Abbott Showcases World’s First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV
Ergodyne Hits the Road to Serve Up Heat Safety with a Side of Guac
Psychologie Berlin's Dr. Dirk Stemper Announces New Book: The Vagus Nerve: Why You Don’t Need a Reset – Real Neuromodulation for Exhaustion, Trauma, and Long COVID
Wounded Warriors Family Support, AMVET Power Announce Strategic Partnership to Empower Veterans
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
11 New Living Soil THCA Strains Now Available at The Hemp Doctor
Evaluating the Potential of a Sleep Intervention Among Youth at High-Risk for Borderline Personality Disorder
ENT and Allergy Associates, LLP Strengthens New Jersey Presence with the Addition of Michael Katz, MD, FACS
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Kaida BioPharma Selected to Present at Two Upcoming Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions